Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Korro Bio, Inc. (KRRO)

Corbus Pharmaceuticals Holdings, Inc. and Korro Bio, Inc. are both Biotechnology companies. Corbus Pharmaceuticals Holdings, Inc. and Korro Bio, Inc. are of similar size ($144.1M and $140.9M). Corbus Pharmaceuticals Holdings, Inc. grew revenue faster over the last twelve months: −73.7% against −81.9%. Across the 12 metrics below, Korro Bio, Inc. leads on 8 and Corbus Pharmaceuticals Holdings, Inc. on 4.

Valuation

Metric CRBP KRRO Biotechnology median
P/E n/m n/m 7.88
P/S 89.99 26.38 11.47
P/B 1.36 1.63 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 22.77 12.73 10.73
Earnings yield (86.69%) (104.49%) (28.84%)
Free cash flow yield (62.56%) (40.49%) (23.03%)

Profitability

Metric CRBP KRRO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (95.58%) (97.69%) (57.72%)
Return on assets (80.85%) (62.03%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBP KRRO Biotechnology median
Revenue growth (TTM) (73.69%) (81.87%) 5.64%
EPS growth (last fiscal year) (60.33%) (33.19%) —
Revenue growth, 5-year CAGR (14.34%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBP KRRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.71 9.55 4.73
Net debt to EBITDA 1.90 0.64 0.96

Dividend

Metric CRBP KRRO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CRBP KRRO Biotechnology median
Market cap 144.09m 140.92m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack